87
60
Growth Score 87 in past quarter
1 pts
Heat Score 60 in past quarter
19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
467956
OrphanPacific Inc develops and markets orphan drugs for rare diseases in Japan, offering comprehensive services from development to sales.
About the Company
OrphanPacific Inc develops and markets orphan drugs for rare diseases in Japan. The company provides a one-stop service from drug development to sales, supporting all areas for pharmaceutical companies. OrphanPacific's innovative business model, known as the Innovative Pharma Model, aims to deliver remedies to patients with unmet medical
needs. The company focuses on therapeutic areas such as endocrinology and metabolic diseases.